Equities

QT Imaging Holdings Inc

QT Imaging Holdings Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.68
  • Today's Change0.08 / 13.33%
  • Shares traded56.53k
  • 1 Year change-93.73%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

QT Imaging Holdings, Inc. is a medical device company engaged in the research, development, and commercialization of body imaging systems using low frequency sound waves. Its medical imaging is critical to the detection, diagnosis, and treatment of disease. The Company offers two products: QT Breast Scanner and QTviewer. QT Breast Scanner is a fixed, mechanical scanner used to evaluate the breast without the use of either ionizing radiation or compression associated with mammography, or the injections required for breast MRI. The QT Breast Scanner provides sub-millimeter, high-definition, image resolution enabling identification of normal and abnormal breast structures and the accurate depiction of the precise shape and location of findings. The QT Breast Scanner creates 3D images of the patient’s breast viewable in the Quantitative Transmission Ultrasound Viewer (QTviewer), a software product designed for healthcare professionals to view the transmission and reflection images.

  • Revenue in USD (TTM)0.00
  • Net income in USD-4.02m
  • Incorporated2021
  • Employees--
  • Location
    QT Imaging Holdings Inc3 Hamilton Landing, Suite 160NOVATO 94949United StatesUSA
  • Phone+1 (415) 842-7250
  • Fax+1 (302) 655-5049
  • Websitehttps://gigcapital5.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
ALR Technologies Inc9.49k-8.00m10.17m6.00------1,071.39-0.0147-0.01470.00002-0.04760.0358----1,581.67-3,015.28-12,861.64----62.49---84,283.24-406,011.30---0.8626---------42.72------
Bionoid Pharma Inc0.001.35m10.80m13.000.1764--7.98--1.131.130.00-0.1744-----------506.64--------------327.24---------31.55--26.01--
PetVivo Holdings Inc975.28k-10.11m10.86m20.00--13.03--11.14-0.6705-0.67050.0620.04170.32570.40516.3748,764.00-337.63-230.77-589.09-467.9983.6066.21-1,036.50-1,501.440.455-1,075.050.0221--5.62---25.67--23.91--
Vivos Therapeutics Inc14.02m-12.05m10.95m114.00--1.73--0.7811-6.98-6.986.881.870.9477--38.84123,000.00-81.41-89.72-166.05-149.7060.0870.20-85.90-113.15----0.00---13.8729.4843.04---8.48--
Scientific Industries Inc10.45m-7.76m12.29m63.00--1.05--1.18-0.9231-0.92311.171.110.73431.139.08165,942.90-54.50---62.11--45.41---74.22--3.15--0.00--------------
STRATA Skin Sciences Inc32.73m-8.31m12.35m99.00--1.09--0.3772-2.37-2.379.352.710.69063.477.81330,606.10-17.54-11.48-24.26-16.5554.3061.28-25.40-17.700.9176-2.690.6141---7.752.24-95.17--23.29--
Dalrada Financial Corporation32.16m-21.34m12.41m0.00--1.41--0.386-0.2388-0.23880.35730.0911.098.863.37---75.10-80.63-239.06--30.1139.23-68.78-63.941.24-21.540.3452--54.35---43.94------
Applied DNA Sciences Inc3.40m-7.52m12.46m53.00--1.01--3.67-11.86-11.862.181.200.20926.835.6864,114.15-45.51-88.57-55.20-121.9125.0444.35-217.48-113.263.76--0.00---26.4327.92-18.73--33.80--
QT Imaging Holdings Inc0.00-4.02m12.86m----0.5917-----0.3999-0.39990.001.010.00-------12.32---16.60--------------0.3042-------45.07------
REMSleep Holdings Inc144.88k-1.81m14.41m6.00--25.06--99.46-0.0012-0.00120.00010.00040.081.694.75---99.82-152.40-122.32-317.98-491.08---1,246.94-2,317.521.47-43.580.1207---36.48--12.13--28.26--
Trinity Biotech plc (ADR)58.65m-22.29m14.55m380.00------0.2482-2.74-2.747.23-19.240.70521.693.74154,347.40-26.80-20.30-35.44-29.5434.2839.92-38.01-29.860.8936-2.161.46---9.10-10.1515.41---31.08--
Autonomix Medical Inc-100.00bn-100.00bn15.01m5.00--2.37----------0.2749----------------------------0.1647-------674.99------
LiveCare Inc0.00-2.34m15.26m----6.47-----0.1411-0.14110.000.04630.00-------424.83---550.62-------------8.180.1888-------344.86------
Cutera Inc169.19m-148.97m15.50m430.00------0.0916-7.46-7.468.46-10.730.45722.083.86393,460.50-40.25-22.00-51.64-30.728.1847.63-88.05-27.242.17-31.342.05---15.865.47-97.76--85.87--
Innovative Eyewear Inc1.53m-7.86m15.53m11.00--2.06--10.15-11.01-11.012.054.810.17791.9715.91139,070.90-91.45---96.06---2.46---514.10--12.85--0.00--74.67---17.28------
Data as of Sep 20 2024. Currency figures normalised to QT Imaging Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

7.04%Per cent of shares held by top holders
HolderShares% Held
Cable Car Capital LLCas of 30 Jun 2024800.00k3.73%
Lynrock Lake LPas of 30 Jun 2024257.87k1.20%
Meteora Capital LLCas of 30 Jun 2024194.49k0.91%
Geode Capital Management LLCas of 30 Jun 202478.74k0.37%
Oxford Financial Group Ltd.as of 30 Jun 202475.57k0.35%
HRT Financial LLCas of 30 Jun 202441.78k0.20%
MML Investors Services LLCas of 30 Jun 202429.24k0.14%
Fifth Third Bank, NA (Investment Management)as of 30 Jun 202411.90k0.06%
Envestnet Asset Management, Inc.as of 30 Jun 202410.01k0.05%
Cambridge Investment Research Advisors, Inc.as of 30 Jun 202410.00k0.05%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.